BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhangdi HJ, Su SB, Wang F, Liang ZY, Yan YD, Qin SY, Jiang HX. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World J Gastroenterol 2019; 25(33): 4835-4849 [PMID: 31543677 DOI: 10.3748/wjg.v25.i33.4835]
URL: https://www.wjgnet.com/1007-9327/full/v25/i33/4835.htm
Number Citing Articles
1
Daphne Pinheiro, Isabelle Dias, Thiago Freire, Alessandra Alves Thole, Ana Carolina Stumbo, Erika Afonso Costa Cortez, Lais de Carvalho, Simone Nunes de Carvalho. Effects of mesenchymal stem cells conditioned medium treatment in mice with cholestatic liver fibrosisLife Sciences 2021; 281: 119768 doi: 10.1016/j.lfs.2021.119768
2
Ya Yang, Yalei Zhao, Lingjian Zhang, Fen Zhang, Lanjuan Li. The Application of Mesenchymal Stem Cells in the Treatment of Liver Diseases: Mechanism, Efficacy, and Safety IssuesFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.655268
3
Nazli Khodayari, Regina Oshins, L. Shannon Holliday, Virginia Clark, Qiang Xiao, George Marek, Borna Mehrad, Mark Brantly. Alpha-1 antitrypsin deficient individuals have circulating extracellular vesicles with profibrogenic cargoCell Communication and Signaling 2020; 18(1) doi: 10.1186/s12964-020-00648-0
4
Asrin Ahmadi, Hossein Niknahad, Huifeng Li, Ali Mobasheri, Ram Kumar Manthari, Negar Azarpira, Khadijeh Mousavi, Bahman Khalvati, Yangfei Zhao, Jianyu Sun, Yuqi Zong, Mohammad Mehdi Ommati, Reza Heidari. The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicityToxicology Letters 2021; 349: 12 doi: 10.1016/j.toxlet.2021.05.012
5
Pragyan Acharya, Komal Chouhan, Sabine Weiskirchen, Ralf Weiskirchen. Cellular Mechanisms of Liver FibrosisFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.671640
6
Bingjian Wen, Chengcheng Zhang, Jingwen Zhou, Zhengyan Zhang, Qishi Che, Hua Cao, Yan Bai, Jiao Guo, Zhengquan Su. Targeted treatment of alcoholic liver disease based on inflammatory signalling pathwaysPharmacology & Therapeutics 2021; 222: 107752 doi: 10.1016/j.pharmthera.2020.107752
7
Haili Wang, Jinying Che, Kai Cui, Wenyue Zhuang, He Li, Jinghui Sun, Jianguang Chen, Chunmei Wang. Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivoPhytomedicine 2021; 88: 153609 doi: 10.1016/j.phymed.2021.153609
8
Sergio C. Oliveira, M. Victoria Delpino, Guillermo Hernán Giambartolomei, Jorge Quarleri, Gary Splitter. Editorial: Advances in Liver Inflammation and Fibrosis Due to Infectious DiseasesFrontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01760
9
Jianping Sheng, Baohang Zhang, Yongfeng Chen, Fuxiang Yu. Capsaicin attenuates liver fibrosis by targeting Notch signaling to inhibit TNF-α secretion from M1 macrophagesImmunopharmacology and Immunotoxicology 2020; 42(6): 556 doi: 10.1080/08923973.2020.1811308
10
Tao Li, GuangYue Su, YuQing Zhao. Anti‐hepatic fibrosis effects of AD‐2 affecting the Raf–MEK signaling pathway and inflammatory factors in thioacetamide‐induced liver injuryJournal of Food Science 2021; 86(6): 2753 doi: 10.1111/1750-3841.15731
11
Yu-long Bao, Li Wang, Hai-ting Pan, Tai-ran Zhang, Ya-hong Chen, Shan-jing Xu, Xin-li Mao, Shao-wei Li. Animal and Organoid Models of Liver FibrosisFrontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.666138
12
Jianxia Wen, Dan Wang, Jian Wang, Ruilin Wang, Shizhang Wei, Yanling Zhao, Chih-Yuan Ko. Astragali Radix Contributes to the Inhibition of Liver Fibrosis via High-Mobility Group Box 1-Mediated Inflammatory Signaling PathwayEvidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5574010
13
Mishghan Zehra, James C. Curry, Sneha S. Pillai, Hari Vishal Lakhani, Cory E. Edwards, Komal Sodhi. Elucidating Potential Profibrotic Mechanisms of Emerging Biomarkers for Early Prognosis of Hepatic FibrosisInternational Journal of Molecular Sciences 2020; 21(13): 4737 doi: 10.3390/ijms21134737
14
Zuleyha Erisgin, Hasan Serdar Mutlu, Yavuz Tekelioglu, Engin Deveci, Ugur Seker. Hepatotoxic effects of melamine exposure from the weaning period in rats: a flow cytometric, electron microscopic, and histopathologic studyToxicology Research 2021; 10(3): 418 doi: 10.1093/toxres/tfab022
15
Mengting Zhou, Naihua Hu, Meichen Liu, Ying Deng, Linfeng He, Chaocheng Guo, Xingtao Zhao, Yunxia Li. A Candidate Drug for Nonalcoholic Fatty Liver Disease: A Review of Pharmacological Activities of Polygoni Multiflori RadixBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5462063
16
Xingtao Zhao, Jing Wang, Ying Deng, Li Liao, Mengting Zhou, Cheng Peng, Yunxia Li. Quercetin as a protective agent for liver diseases: A comprehensive descriptive review of the molecular mechanismPhytotherapy Research 2021; 35(9): 4727 doi: 10.1002/ptr.7104
17
Hui Li. Angiogenesis in the progression from liver fibrosis to cirrhosis and hepatocelluar carcinomaExpert Review of Gastroenterology & Hepatology 2021; 15(3): 217 doi: 10.1080/17474124.2021.1842732
18
Ibrahim A Ahmed, Miran A Jaffa, Mayssam Moussa, Duaa Hatem, Ghewa A El-Achkar, Rola Al Sayegh, Mia Karam, Eva Hamade, Aida Habib, Ayad A Jaffa. Plasma Kallikrein as a Modulator of Liver Injury/RemodelingFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.715111
19
Chang Fan, Fu Rong Wu, Jia Fu Zhang, Hui Jiang. A Network Pharmacology Approach to Explore the Mechanisms of Shugan Jianpi Formula in Liver FibrosisEvidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/4780383
20
Luiza M. Karzakova, Antonina L. Ivanova, Sergei I. Kudryashov, Evgeniya V. Sokolova, Tatyana S. Lutkova. IMMUNE MECHANISMS FOR THE DEVELOPMENT OF HEPATORENAL SYNDROME IN LIVER CIRRHOSISActa medica Eurasica 2020; (3): 7 doi: 10.47026/2413-4864-2020-3-7-19
21
Simona-Rebeca Ignat, Sorina Dinescu, Anca Hermenean, Marieta Costache. Cellular Interplay as a Consequence of Inflammatory Signals Leading to Liver Fibrosis DevelopmentCells 2020; 9(2): 461 doi: 10.3390/cells9020461